Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
UBS
Citi
Baxter
Argus Health
Moodys
Cipla
Federal Trade Commission
Express Scripts

Generated: November 15, 2018

DrugPatentWatch Database Preview

Drugs in Development Information for Imeglimin

« Back to Dashboard

US Patents for Imeglimin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Imeglimin ➤ Try a Free Trial Separation of triazine derivatives enantiomers using tartaric acid Poxel (Lyons, FR) ➤ Try a Free Trial
Imeglimin ➤ Try a Free Trial Biguanide compositions and methods of treating metabolic disorders Elcelyx Therapeutics, Inc (San Diego, CA) ➤ Try a Free Trial
Imeglimin ➤ Try a Free Trial Process of isolating enantiomer components from enantiomer mixtures by particle-size-controlled crystallization Poxel (Lyons, FR) ➤ Try a Free Trial
Imeglimin ➤ Try a Free Trial Biguanide compositions and methods of treating metabolic disorders ELCELYX THERAPEUTICS, INC. (San Diego, CA) ➤ Try a Free Trial
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Imeglimin

Drugname Country Document Number Estimated Expiration Related US Patent
Imeglimin Argentina 091089 2031-01-07 ➤ Try a Free Trial
Imeglimin Argentina 091739 2031-01-07 ➤ Try a Free Trial
Imeglimin Australia 2011317140 2030-10-19 ➤ Try a Free Trial
Imeglimin Australia 2011317143 2030-10-19 ➤ Try a Free Trial
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cipla
Express Scripts
Merck
Chubb
Fish and Richardson
Queensland Health
Healthtrust
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.